Artificial Liver Support -- Pipe Dream or Reality?

Abstract
Fulminant hepatic failure is characterized by the rapid appearance of jaundice, coagulopathy, and encephalopathy and reflects severe hepatocellular injury or necrosis. Acute viral hepatitis and drug-induced liver injury account for the vast majority of cases in developed nations; other causes include toxins, venous-outflow obstruction, and ischemia. Despite advances in our understanding of the pathophysiologic features of the disease and the establishment of specialized liver-failure units, mortality from fulminant hepatic failure ranges from 50 to 80 percent, depending on the cause.The liver destruction in fulminant hepatic failure is potentially reversible; the liver usually returns to normal in people who recover. . . .